VICPLAS INTERNATIONAL LTD Vicplas International Ltd Share Price
Equities
569
SG1G57870584
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.115 SGD | -4.96% |
|
+9.52% | -22.82% |
| Sales 2022 | 137M 100M 8.36B | Sales 2023 | 133M 97.96M 8.17B | Capitalization | 75.13M 55.14M 4.6B |
|---|---|---|---|---|---|
| Net income 2022 | 8M 5.87M 490M | Net income 2023 | 4M 2.94M 245M | EV / Sales 2022 | 0.86 x |
| Net Debt 2022 | 18.36M 13.47M 1.12B | Net Debt 2023 | 8.37M 6.14M 512M | EV / Sales 2023 | 0.63 x |
| P/E ratio 2022 |
11.5
x | P/E ratio 2023 |
17.9
x | Employees | - |
| Yield 2022 |
2.31% | Yield 2023 |
3.06% | Free-Float | 27.77% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -4.96% | ||
| 1 week | +9.52% | ||
| Current month | -3.36% | ||
| 1 month | -9.45% | ||
| 3 months | -14.18% | ||
| 6 months | -10.85% | ||
| Current year | -22.82% |
1 week
0.11
0.12
1 month
0.110.12
Current year
0.100.15
1 year
0.100.17
3 years
0.100.27
5 years
0.070.74
10 years
0.050.74
| Managers | Title | Age | Since |
|---|---|---|---|
Walter Tarca
CEO | Chief Executive Officer | 67 | 01/16/01 |
Ying Hui Gan
DFI | Director of Finance/CFO | 45 | 01/08/01 |
Chin Liang Toon
CTO | Chief Tech/Sci/R&D Officer | 46 | 01/14/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 01/16/01 | |
Cher Yan Ng
BRD | Director/Board Member | 65 | 03/10/03 |
Wico Yeo
CHM | Chairman | 57 | 10/08/10 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 0.115 | -4.96% | 85,500 |
| 24/24/24 | 0.121 | +15.24% | 49,300 |
| 23/24/23 | 0.105 | -3.67% | 5,000 |
| 22/24/22 | 0.109 | +3.81% | 1,500 |
| 19/24/19 | 0.105 | -11.76% | 64,500 |
Delayed Quote Singapore S.E., April 26, 2024 at 02:29 pm IST
More quotes
Vicplas International Ltd is a Singapore-based holding company. The Company operates through two segments: Medical devices and Pipes & pipe fittings. Its Medical devices segment designs, develops and manufactures sterile and non-sterile medical devices. It operates Medical devices segment, through its subsidiaries, Forefront Medical Technology (Pte) Ltd, Forefront Medical Investment Pte. Ltd. and XentiQ (Pte.) Ltd. in Singapore; Forefront (Xiamen) Medical Devices Co., Ltd and Forefront Medical Technology (Jiangsu) Co., Ltd in China; and Arrow Medical Limited in the United Kingdom. Its Pipes & pipe fittings segment manufactures and distributes piping systems for industries, including waste and potable water systems for residential homes, schools, commercial and industrial buildings, and underground electrical systems. It operates Pipes & pipe fittings segment, through its wholly owned subsidiaries, Vicplas Holdings Pte Ltd in Singapore and Rimplas Industries Sdn. Bhd. in Malaysia.
Calendar
25/09/2024
- Q4 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -22.82% | 43.17M | |
| +73.17% | 12.38B | |
| -18.74% | 7.92B | |
| +16.15% | 7.2B | |
| +4.81% | 5.84B | |
| +5.99% | 5.01B | |
| +27.07% | 4.53B | |
| -21.67% | 3.88B | |
| -40.82% | 2.23B | |
| +1.49% | 2.02B |
- Stock Market
- Equities
- 569 Stock
